SEC Comment Letter for Autolus Therapeutics plc (AUTL) (CIK 0001730463) (AUTL) — Jul 22, 2019
Autolus Therapeutics plc (AUTL) (CIK 0001730463)
Date: July 22, 2019 · CIK: 0001730463 · Accession: 0000000000-19-011382
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232690
Letter
July 22, 2019 Christian Itin Chief Executive Officer Autolus Therapeutics plc Forest House 58 Wood Lane London W12 7RZ United Kingdom Re:Autolus Therapeutics plc Registration Statement on Form F-3 Filed July 17, 2019 File No. 333-232690 Dear Mr. Itin: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Courtney T. Thorne, Esq.
Show Raw Text
July 22, 2019
Christian Itin
Chief Executive Officer
Autolus Therapeutics plc
Forest House
58 Wood Lane
London W12 7RZ
United Kingdom
Re:Autolus Therapeutics plc
Registration Statement on Form F-3
Filed July 17, 2019
File No. 333-232690
Dear Mr. Itin:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Courtney T. Thorne, Esq.